Kitazato Osingo per osake

Mitä Kitazato tekee? Kitazato Corp is a health care company headquartered in Fuji-shi, Japan. The company engages in the manufacturing and sale of medical devices, reagents, and related products specifically for infertility treatment. Kitazato Corp specializes in reproductive engineering technology, including artificial insemination, in vitro fertilization, cell cryopreservation, and regenerative medicine. Its product portfolio includes consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection. The company offers medical devices for infertility treatment categorized into media, cryo devices, medical devices, and micro tools. Additionally, Kitazato Corp is involved in the manufacture and sale of medical equipment parts, genetic testing services, medical equipment for the elderly, market research, acquisition of local licenses, and contract management of living cells. The firm distributes its products globally, serving markets in Japan, Europe, the United States, China, and India. Kitazato Corp completed its initial public offering on June 25, 2025, with the ticker symbol 368A.T and ISIN JP3237550003. The company's website is https://www.kitazato.co.jp/. Kitazato on yksi Eurpooliin suosituimmista yhtiöistä.